データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
132112-35-7CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C.Cl.OVSHFRHVKMYGBJL-CKUXDGONSA-N132112-35-7化学的特性White Solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明(–)-Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. In vivo, (–)-ropivacaine induces complete impairment of proprioception, motor function, and nociception in the hindleg of rats when 100 μL of an 8 mM solution is injected percutaneously into the sciatic nerve. (–)-Ropivacaine depresses myocardial contractile force in isolated rat hearts less potently than (±)-ropivacaine, as well as (–)- and (±)-bupivacaine . Formulations containing (–)-ropivacaine have been used as local anesthetics during surgery and childbirth.
使用Ropivacaine hydrochloride monohydrate has been used as an analyte in tandem mass spectrometry and as an amide-based local anaesthetic to test its effect on breast cancer cell methylation.
一般的な説明Ropivacaine has lidocaine-related structure with tertiary amine side chains.It is a pure S(-)enantiomer with a propyl group on the piperidine nitrogen atom.
定義ChEBI: The monohydrate form of (S)-ropivacaine hydrochloride.
読み込み中…
読み込み中…
現在のフィルター条件では反応記録がありません。
読み込み中…